The leader in know how and know why in oncology
We leverage provider and payer relationships, oncology experience and proprietary analytics to deliver actionable insights that drive successful market access.
Featured Insights
Article
Navigating the 340B Maze Amid the Inflation Reduction Act
As the Inflation Reduction Act (IRA) introduces new Maximum Fair Pricing (MFP) rules, integrated delivery networks (IDNs) and manufacturers will face the complexities of navigating overlapping 340B discounts and MFPs.
Read More
Revolutionizing Cancer Care: EOM's Second Wind and its Current Impact on Community Oncology Practices
The second Enhancing Oncology Model (EOM) application cycle closed on September 16, signaling shifts in community oncology. Explore our 2024 Community Oncology Report to understand EOM’s current impact and changes from this round.
Ashutosh Sheth
Article
Bispecific Therapies in Community Oncology: Bridging Insights from CPC+CBEx and Beyond
Explore key takeaways from CPC+CBEx on bispecific therapies, highlighting collaboration between hospitals and community practices to expand access and tackle financial challenges.
Daniel Buchenberger
Article
Community Oncology: Awareness v Action in the Face of the IRA
The Inflation Reduction Act (IRA) will significantly impact community oncology practice financials. As we approach this shift, our latest research from the 2024 Community Oncology Report reveals a current gap between awareness and action.
Emma Bijesse
The HMP Market Access Insights team helps us understand the interconnectivity between our major customer segments on really important issues and lead us toward better planning and business decisions.
Our Team
Lee Blansett
Executive Vice President
Cindy Chen
Head of Data Analytics
Chris Van Denburg
Director
Emma Bijesse
Director
Upcoming Events
07 Nov
08 Nov
Insights to Access
Our podcast featuring interviews with experts in the oncology management space.
